Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4285333
Max Phase: Preclinical
Molecular Formula: C28H27ClN4O2
Molecular Weight: 487.00
Molecule Type: Small molecule
Associated Items:
ID: ALA4285333
Max Phase: Preclinical
Molecular Formula: C28H27ClN4O2
Molecular Weight: 487.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)C1(Cc2ccccc2)CN(c2ccccc2)Cc2nnn(Cc3ccccc3Cl)c21
Standard InChI: InChI=1S/C28H27ClN4O2/c1-2-35-27(34)28(17-21-11-5-3-6-12-21)20-32(23-14-7-4-8-15-23)19-25-26(28)33(31-30-25)18-22-13-9-10-16-24(22)29/h3-16H,2,17-20H2,1H3
Standard InChI Key: ALXVLCMXUDVJAZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 487.00 | Molecular Weight (Monoisotopic): 486.1823 | AlogP: 5.04 | #Rotatable Bonds: 7 |
Polar Surface Area: 60.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 0.26 | CX LogP: 6.24 | CX LogD: 6.24 |
Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.34 | Np Likeness Score: -0.96 |
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |
Source(1):